Alignment Healthcare (NASDAQ:ALHC) EVP Joseph Konowiecki Sells 23,511 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) EVP Joseph Konowiecki sold 23,511 shares of the company’s stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $8.61, for a total value of $202,429.71. Following the sale, the executive vice president owned 1,080,305 shares of the company’s stock, valued at $9,301,426.05. The trade was a 2.13% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Alignment Healthcare Trading Down 4.0%

Shares of ALHC stock opened at $8.35 on Friday. Alignment Healthcare, Inc. has a fifty-two week low of $8.27 and a fifty-two week high of $25.12. The stock’s fifty day moving average price is $14.96 and its two-hundred day moving average price is $17.68. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. The company has a market cap of $1.73 billion, a PE ratio of 43.95 and a beta of 1.11.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The company had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.31 billion. During the same quarter in the previous year, the firm earned $0.07 EPS. Alignment Healthcare’s revenue was up 31.6% on a year-over-year basis. Equities analysts predict that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Institutional Trading of Alignment Healthcare

Hedge funds have recently made changes to their positions in the company. Allworth Financial LP grew its holdings in shares of Alignment Healthcare by 8.9% during the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock worth $137,000 after purchasing an additional 566 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in Alignment Healthcare by 9.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 11,445 shares of the company’s stock valued at $202,000 after buying an additional 962 shares during the last quarter. GAMMA Investing LLC raised its holdings in Alignment Healthcare by 46.6% in the 2nd quarter. GAMMA Investing LLC now owns 3,368 shares of the company’s stock valued at $80,000 after buying an additional 1,070 shares during the last quarter. Versant Capital Management Inc boosted its position in Alignment Healthcare by 463.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after buying an additional 1,135 shares during the period. Finally, Nykredit A S acquired a new stake in Alignment Healthcare during the 2nd quarter worth approximately $36,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: Some analysts remain constructive after the selloff. Coverage continues to describe ALHC as a potential bargain, and the stock retains a consensus “Moderate Buy” rating, although price targets may not yet reflect the latest concerns. Analysts Are Bullish on Alignment Healthcare
• Neutral Sentiment: EVP Joseph Konowiecki sold 23,511 shares for approximately $202,430 at an average price of $8.61. The filing states that the sale covered tax-withholding obligations related to vested equity awards, making it less indicative of management’s investment outlook. SEC Filing for Joseph Konowiecki
• Neutral Sentiment: CEO John Kao previously sold 27,400 shares for $356,200 under a pre-arranged Rule 10b5-1 plan. While the transaction reduced his direct holdings by 4.43%, its scheduled nature limits the bearish signal. SEC Filing for John Kao
• Negative Sentiment: Investors reacted negatively to management’s disclosures at the Baird conference, particularly uncertainty surrounding Medicare Advantage star ratings. Those ratings can influence reimbursement, enrollment and profitability, so limited visibility increased concerns about Alignment’s earnings outlook. Hagens Berman Conference Investigation Update
• Negative Sentiment: Reports also highlighted potential Medicare Advantage reforms, creating uncertainty about how regulatory changes could affect Alignment’s economics and future growth. Alignment Healthcare Faces Medicare Advantage Reform
• Negative Sentiment: Multiple law firms announced securities-fraud investigations following the steep conference-related selloff. The investigations do not establish wrongdoing, but they add potential litigation, reputational and headline risk. Securities Fraud Investigation Into Alignment Healthcare

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of research reports. Raymond James Financial cut shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and dropped their target price for the stock from $22.00 to $19.00 in a report on Monday, August 3rd. Barclays decreased their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Weiss Ratings reissued a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 4th. Seven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $23.60.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care.